Navigation Links
Genaera Corporation Elects Paul K. Wotton to Board of Directors
Date:6/30/2008

PLYMOUTH MEETING, Pa., June 30 /PRNewswire-FirstCall/ -- Genaera Corporation (Nasdaq: GENR) today announced the election of Paul K. Wotton, Ph.D., to Genaera's Board of Directors, bringing the membership total to seven. Dr. Wotton is expected to serve for the remainder of the Board's existing term through the Company's 2009 Annual Meeting.

"We are extremely pleased to add Paul Wotton to our Board of Directors. He has a proven record of success in business development, commercializing new business opportunities, and closing negotiations," said Jack Armstrong, president and CEO of Genaera. "I believe Paul's areas of expertise will be invaluable to Genaera. The management team and I look forward to working closely with Paul and the rest of our Board members to further develop strategic relationships."

Wotton previously served as CEO of Topigen Pharmaceuticals Inc., where he successfully completed multiple financial transactions that enabled the company to advance two preclinical programs to Phase 2 clinical trials. Prior to joining Topigen, Dr. Wotton was global head of business development at SkyePharma PLC, where he managed the business development and marketing function as well as implemented the largest drug delivery transaction at that time. Dr. Wotton has also served in senior-level positions at Eurand International BV, PENWEST Pharmaceuticals, Abbott Laboratories and Merck, Sharp and Dohme. He also currently serves on the board of Antares Pharma and is past chairman of the Emerging Companies Advisory Board of BIOTECanada.

"I am very pleased to join Genaera's Board. I believe Genaera has the opportunity to develop MSI-1436 as a novel therapy with the potential to treat both type 2 diabetes and obesity," states Paul
'/>"/>

SOURCE Genaera Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Genaera Corporation to Present at BIO Business Forum
2. Genaera Corporation Announces First Quarter Financial Results
3. Genaera Corporation Announces 2007 Financial Results
4. Genaera Corporation to Participate in Diabetes and Obesity Panel at RBC Capital Markets Healthcare Conference
5. Genaera Corporation Announces Third Quarter Financial Results
6. Genaera to Present at Biotech 2007 and BIO InvestorForum
7. Genaera Elects New Board Member and Announces Executive Appointments
8. BioTime, Inc. and Embryome Sciences, Inc. Sign Agreement With International Stem Cell Corporation to Provide Unique Human Stem Cell Lines for Research Use
9. U.S. Commerce Secretary Gutierrez Cuts Ribbon on MaxWell Biocorporations New Pharmaceutical Development Center and Quality Control Laboratory in Ukraine
10. FierceBiotech Names NanoBio Corporation as One of the Fierce 15 Biotech Companies of 2008
11. Allegiance Equity Corporation announces collaboration with Canadian Dairy Commission and Guelph Food Technologies Corporation for Alzheimers and Dementia formulation GG-XT
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... , July 28, 2015  Faced with increasing ... are palliative rather than symptomatic, the global healthcare ... existing therapies capable of curing or significantly changing ... starting to look towards regenerative medicine as a ... new paradigm in human health with the potential ...
(Date:7/27/2015)... ... July 27, 2015 , ... Production of high tenacity ... past few years in the EU. For instance, it surpassed the EUR 106 million ... million mark in 2010. Germany is a major producer, while Italy is a key ...
(Date:7/27/2015)... , July 27, 2015 According ... by Type (Home-brew Media, Pre-formulated Media), by Application (Biobanking, Regenerative ... , Europe , Asia-Pacific ... 2019", The global biopreservation media market was valued at $247.7 ... $571.5 million by 2019, at a CAGR of 18.2% between ...
(Date:7/26/2015)... ... July 26, 2015 , ... Maine Standards Company, LLC ... linearity test kit. The VALIDATE® ANEMIA kit contains Ferritin, Folate, and Vitamin B12 ... the CLSI recommended “equal delta” method for linearity testing and is liquid, ready-to-use. ...
Breaking Biology Technology:Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 2Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 3Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 4Stem Cell Therapy to Redefine Regenerative Medicine, says Frost & Sullivan 5High Tenacity Filament Yarn of Viscose Rayon Consumption to Grow Swiftly in the EU, Forecasts BAC Reports in New Study Available at MarketPublishers.com 2Global Biopreservation Media Market to be Worth $571.5 Million by 2019 2Global Biopreservation Media Market to be Worth $571.5 Million by 2019 3Maine Standards Company, LLC Announces Release of VALIDATE® ANEMIA Calibration Verification / Linearity Test Kit 2
... , , ... , The ribonuclease protection assay (RPA) ... mRNA species. The assay was made possible,by the discovery and characterization ... properties that,make them well suited for the preparation of highly specific,hybridization ...
... , , , Product Literature Center Articles , ... , , ... Expression Patterns with Improved Tools for Target Amplification , , ... with FastStart Taq DNA Polymerase and the Novel FastStart High Fidelity PCR System , ...
... , , , ... , Like all components of a PCR or RT-PCR assay, ... DNA, RNA, nucleases,or a variety of microorganisms. These contaminants,often contribute to suboptimal amplification ... , , Roche Applied Sciences LightCycler Kits ...
Cached Biology Technology:RNase Protection Assay (RPA),Using DIG-Labeled RNA Probes 2Roche Diagnostics Corporation 2Roche Diagnostics Corporation 3Roche Diagnostics Corporation 4Roche Diagnostics Corporation 5Enjoy a Greater Sense of Security,with PCR-Grade Water 2
(Date:7/2/2015)... Research and Markets( http://www.researchandmarkets.com/research/jvft55/next_generation ... Generation Biometrics Market by Application, Technology, Function & Geography ... offering. The next generation biometrics market is ... CAGR of 17.9% between 2015 and 2020 ... market. Safran SA ( France ...
(Date:6/29/2015)... DUBLIN , June 24, 2015 ... the addition of the "Latin America Biomedical Sensors ... to their offering. The Latin America Biomedical ... at a CAGR of 2.04% over the period 2014-2020 ... that are adaptable to the genetic formulation of each ...
(Date:6/25/2015)... -- TAKE Solutions Ltd., a global business technology solutions provider, ... and Trademark Office (USPTO) for its "Method for Optimizing ... Accelerators to reduce the time taken to standardize trial ... the accelerators), thus reducing time to market. ... heart of the patented Clinical Data Standardization Process are ...
Breaking Biology News(10 mins):Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 2Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 3Latin America Biomedical Sensors Market Report 2015-2020 2TAKE Solutions Awarded Patent By USPTO 2
... Molecular and Cell Biology (IMCB) and the Singapore Bioimaging ... controls both obesity and atherosclerosis. The team demonstrated, for ... gene were resistant to weight gain and atherosclerosis via ... its downstream signalling molecule mTor. These groundbreaking findings were ...
... Function and significance of the biological clocks in polar ... Institute entitled PolarTime starting July 1st, 2012. It is ... Helmholtz Association. PolarTime, coordinated by the Alfred Wegener Institute ... up to five years with approximately three million euros ...
... in German . , One bit of ... about 3 million magnetic atoms. Researchers from Karlsruhe, Strasbourg, and ... per molecule. By an electric pulse, the metal-organic molecule can ... low-conductive, non-magnetic state. This novel correlation for molecules is now ...
Cached Biology News:Groundbreaking discovery of mechanism that controls obesity, atherosclerosis 2Just a question of time? 2Just a question of time? 3Nature: Molecule changes magnetism and conductance 2
... J. Karn (1995) This volume ... and methods for the study of major ... reverse transcriptase, ribonuclease H, integrase and protease. ... binding assays; Tat and Rev assays; HIV/CD4 ...
Monkey IL-2 ELISPOT Kit with white/opague microtiter plates...
Tachykinin (H-2)...
Human GATA-2 Affinity Purified Polyclonal Ab...
Biology Products: